In line with these findings, blockade of the IL-6 receptor reduces tumour growth and angiogenesis in vivo [42], and the expression of IL-6 and TNF-α in OSCC cell lines correlated with the metastatic phenotype [43, 44]. The gene discussed is TNF; the disease is neoplasm.